1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cancer Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Protein Biomarker
  • 1.2.3 Genetic Biomarker
• 1.3 Market by Application
  • 1.3.1 Global Cancer Biomarker Market Share by Application: 2020 VS 2026
  • 1.3.2 Diagnostics
  • 1.3.3 Research
  • 1.3.4 Prognostics
  • 1.3.5 Risk Assessment
  • 1.3.6 Other Applications
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Biomarker Market Perspective (2015-2026)
• 2.2 Global Cancer Biomarker Growth Trends by Regions
  • 2.2.1 Cancer Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Biomarker Players by Market Size
  • 3.1.1 Global Top Cancer Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Biomarker Revenue Market Share by Players (2015-2020)
• 3.2 Global Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cancer Biomarker Revenue
• 3.4 Global Cancer Biomarker Market Concentration Ratio
  • 3.4.1 Global Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Biomarker Revenue in 2019
• 3.5 Key Players Cancer Biomarker Area Served
• 3.6 Key Players Cancer Biomarker Product Solution and Service
• 3.7 Date of Enter into Cancer Biomarker Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biomarker Breakdown Data by Type (2015-2026)

• 4.1 Global Cancer Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Biomarker Forecasted Market Size by Type (2021-2026)

5 Cancer Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Cancer Biomarker Historic Market Size by Application (2015-2020)
• 5.2 Global Cancer Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Biomarker Market Size (2015-2026)
• 6.2 North America Cancer Biomarker Market Size by Type (2015-2020)
• 6.3 North America Cancer Biomarker Market Size by Application (2015-2020)
• 6.4 North America Cancer Biomarker Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Cancer Biomarker Market Size (2015-2026)
• 7.2 Europe Cancer Biomarker Market Size by Type (2015-2020)
• 7.3 Europe Cancer Biomarker Market Size by Application (2015-2020)
• 7.4 Europe Cancer Biomarker Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Cancer Biomarker Market Size (2015-2026)
• 8.2 China Cancer Biomarker Market Size by Type (2015-2020)
• 8.3 China Cancer Biomarker Market Size by Application (2015-2020)
• 8.4 China Cancer Biomarker Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Cancer Biomarker Market Size (2015-2026)
• 9.2 Japan Cancer Biomarker Market Size by Type (2015-2020)
• 9.3 Japan Cancer Biomarker Market Size by Application (2015-2020)
• 9.4 Japan Cancer Biomarker Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Cancer Biomarker Market Size (2015-2026)
• 10.2 Southeast Asia Cancer Biomarker Market Size by Type (2015-2020)
• 10.3 Southeast Asia Cancer Biomarker Market Size by Application (2015-2020)
• 10.4 Southeast Asia Cancer Biomarker Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Cancer Biomarker Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Cancer Biomarker Business (2015-2020))
  • 11.1.5 Thermo Fisher Scientific Recent Development
• 11.2 Bio-Rad Laboratories
  • 11.2.1 Bio-Rad Laboratories Company Details
  • 11.2.2 Bio-Rad Laboratories Business Overview
  • 11.2.3 Bio-Rad Laboratories Cancer Biomarker Introduction
  • 11.2.4 Bio-Rad Laboratories Revenue in Cancer Biomarker Business (2015-2020)
  • 11.2.5 Bio-Rad Laboratories Recent Development
• 11.3 Roche Diagnostics
  • 11.3.1 Roche Diagnostics Company Details
  • 11.3.2 Roche Diagnostics Business Overview
  • 11.3.3 Roche Diagnostics Cancer Biomarker Introduction
  • 11.3.4 Roche Diagnostics Revenue in Cancer Biomarker Business (2015-2020)
  • 11.3.5 Roche Diagnostics Recent Development
• 11.4 Qiagen
  • 11.4.1 Qiagen Company Details
  • 11.4.2 Qiagen Business Overview
  • 11.4.3 Qiagen Cancer Biomarker Introduction
  • 11.4.4 Qiagen Revenue in Cancer Biomarker Business (2015-2020)
  • 11.4.5 Qiagen Recent Development
• 11.5 Illumina
  • 11.5.1 Illumina Company Details
  • 11.5.2 Illumina Business Overview
  • 11.5.3 Illumina Cancer Biomarker Introduction
  • 11.5.4 Illumina Revenue in Cancer Biomarker Business (2015-2020)
  • 11.5.5 Illumina Recent Development
• 11.6 GE Healthcare
  • 11.6.1 GE Healthcare Company Details
  • 11.6.2 GE Healthcare Business Overview
  • 11.6.3 GE Healthcare Cancer Biomarker Introduction
  • 11.6.4 GE Healthcare Revenue in Cancer Biomarker Business (2015-2020)
  • 11.6.5 GE Healthcare Recent Development
• 11.7 Agilent Technologies
  • 11.7.1 Agilent Technologies Company Details
  • 11.7.2 Agilent Technologies Business Overview
  • 11.7.3 Agilent Technologies Cancer Biomarker Introduction
  • 11.7.4 Agilent Technologies Revenue in Cancer Biomarker Business (2015-2020)
  • 11.7.5 Agilent Technologies Recent Development
• 11.8 Biomérieux SA
  • 11.8.1 Biomérieux SA Company Details
  • 11.8.2 Biomérieux SA Business Overview
  • 11.8.3 Biomérieux SA Cancer Biomarker Introduction
  • 11.8.4 Biomérieux SA Revenue in Cancer Biomarker Business (2015-2020)
  • 11.8.5 Biomérieux SA Recent Development
• 11.9 Merck & Co.
  • 11.9.1 Merck & Co. Company Details
  • 11.9.2 Merck & Co. Business Overview
  • 11.9.3 Merck & Co. Cancer Biomarker Introduction
  • 11.9.4 Merck & Co. Revenue in Cancer Biomarker Business (2015-2020)
  • 11.9.5 Merck & Co. Recent Development
• 11.10 Abbott Laboratories
  • 11.10.1 Abbott Laboratories Company Details
  • 11.10.2 Abbott Laboratories Business Overview
  • 11.10.3 Abbott Laboratories Cancer Biomarker Introduction
  • 11.10.4 Abbott Laboratories Revenue in Cancer Biomarker Business (2015-2020)
  • 11.10.5 Abbott Laboratories Recent Development
• 11.11 Becton, Dickinson and Company
  • 10.11.1 Becton, Dickinson and Company Company Details
  • 10.11.2 Becton, Dickinson and Company Business Overview
  • 10.11.3 Becton, Dickinson and Company Cancer Biomarker Introduction
  • 10.11.4 Becton, Dickinson and Company Revenue in Cancer Biomarker Business (2015-2020)
  • 10.11.5 Becton, Dickinson and Company Recent Development
• 11.12 Danaher Corporation
  • 10.12.1 Danaher Corporation Company Details
  • 10.12.2 Danaher Corporation Business Overview
  • 10.12.3 Danaher Corporation Cancer Biomarker Introduction
  • 10.12.4 Danaher Corporation Revenue in Cancer Biomarker Business (2015-2020)
  • 10.12.5 Danaher Corporation Recent Development
• 11.13 Myriad Genetics
  • 10.13.1 Myriad Genetics Company Details
  • 10.13.2 Myriad Genetics Business Overview
  • 10.13.3 Myriad Genetics Cancer Biomarker Introduction
  • 10.13.4 Myriad Genetics Revenue in Cancer Biomarker Business (2015-2020)
  • 10.13.5 Myriad Genetics Recent Development
• 11.14 Sysmex Corporation
  • 10.14.1 Sysmex Corporation Company Details
  • 10.14.2 Sysmex Corporation Business Overview
  • 10.14.3 Sysmex Corporation Cancer Biomarker Introduction
  • 10.14.4 Sysmex Corporation Revenue in Cancer Biomarker Business (2015-2020)
  • 10.14.5 Sysmex Corporation Recent Development
• 11.15 Hologic
  • 10.15.1 Hologic Company Details
  • 10.15.2 Hologic Business Overview
  • 10.15.3 Hologic Cancer Biomarker Introduction
  • 10.15.4 Hologic Revenue in Cancer Biomarker Business (2015-2020)
  • 10.15.5 Hologic Recent Development
• 11.16 Quest Diagnostics
  • 10.16.1 Quest Diagnostics Company Details
  • 10.16.2 Quest Diagnostics Business Overview
  • 10.16.3 Quest Diagnostics Cancer Biomarker Introduction
  • 10.16.4 Quest Diagnostics Revenue in Cancer Biomarker Business (2015-2020)
  • 10.16.5 Quest Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Cancer Biomarker Scope and Market Size
Cancer Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Protein Biomarker
Genetic Biomarker

Market segment by Application, split into
Diagnostics
Research
Prognostics
Risk Assessment
Other Applications

Based on regional and country-level analysis, the Cancer Biomarker market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics